Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
11 p, 529.4 KB Nivolumab and sunitinib combination in advanced soft tissue sarcomas : A multicenter, single-arm, phase Ib/II trial / Martin-Broto, J. (Universidad de Sevilla) ; Hindi, Nadia (Universidad de Sevilla) ; Grignani, G. (Candiolo Cancer Institute) ; Martinez-Trufero, J. (Hospital Universitario Miguel Servet (Saragossa)) ; Redondo, A. (Hospital Universitario La Paz (Madrid)) ; Valverde, Claudia (Vall d'Hebron Institut d'Oncologia) ; Stacchiotti, S. (Istituto Nazionale Tumori) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; D'Ambrosio, L. (Candiolo Cancer Institute) ; Gutierrez, A. (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Perez-Vega, H. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Encinas-Tobajas, V. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; De Álava, Enrique (Universidad de Sevilla) ; Collini, Paola (Istituto Nazionale Tumori) ; Peña-Chilet, M. (Hospital Virgen Del Rocio) ; Dopazo, J. (Hospital Virgen Del Rocío) ; Carrasco-Garcia, I. (Universidad de Sevilla) ; Lopez-Alvarez, M. (Universidad de Sevilla) ; Moura, D.S. (Universidad de Sevilla) ; Lopez-Martin, Jose A (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Universitat Autònoma de Barcelona
Sarcomas exhibit low expression of factors related to immune response, which could explain the modest activity of PD-1 inhibitors. A potential strategy to convert a cold into an inflamed microenvironment lies on a combination therapy. [...]
2020 - 10.1136/jitc-2020-001561
Journal for immunotherapy of cancer, Vol. 8 Núm. 2 (17 2020) , p. e001561  
2.
10 p, 1.2 MB SELNET clinical practice guidelines for soft tissue sarcoma and GIST / Blay, Jean-Yves (Léon Bérard Center (Lyon)) ; Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Bollard, Julien (Léon Bérard Center (Lyon)) ; Aguiar Júnior, Samuel (A.C.Camargo Cancer Center (Brasil)) ; Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ; Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ; Badilla-González, Ronald (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ; Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ; Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ; Caro-Sánchez, C.H.S. (Instituto Nacional de Cancerología (Tlalpan)) ; Carvajal, B. (Fundación GIST México (Mexico)) ; Carvajal Montoya, A. (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ; Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ; Clara, Miguel (Instituto Nacional de Cancerología (Tlaplan)) ; Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ; Cuellar, M. (Fundación GIST México (Mexico)) ; Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ; Dominguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ; Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Dufresne, Armelle (Léon Bérard Center (Lyon)) ; Eriksson, Mikael (Skane University Hospital (Lund)) ; Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Fernandez, Piga (Fundación GIST (Xile)) ; Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ; Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ; Gouin, François (Léon Bérard Center (Lyon)) ; Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ; Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Jimenez, Natalia (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ; Karanian, Marie (Léon Bérard Center (Lyon)) ; Kasper, Bernd (University of Heidelberg (Mannheim)) ; Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ; Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ; Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ; Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ; Morales Pérez, José Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ; Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ; Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ; Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ; Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ; Salas, Rodrigo (Fundación GIST México (Mexico)) ; Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ; Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Valverde, Claudía María (Hospital Universitari Vall d'Hebron) ; Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ; Zamora Estrada, Esteban (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ; Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
2022 - 10.1016/j.ctrv.2021.102312
Cancer Treatment Reviews, Vol. 102 (january 2022) , p. 102312  
3.
10 p, 1.4 MB SELNET clinical practice guidelines for bone sarcoma / Blay, Jean-Yves (Léon Bérard Center (Lyon)) ; Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Bollard, Julien (Léon Bérard Center) ; Aguiar Júnior, Samuel (A.C.Camargo Cancer Center) ; Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ; Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ; Badilla-González, Ronald (Hospital Dr. R. A. Calderón Guardia (San José)) ; Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ; Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ; CHS, Caro Sánchez (Instituto Nacional de Cancerologia (Tlalpan)) ; Carvajal Montoya, A. (Hospital Dr. R. A. Calderón Guardia (San José)) ; Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ; Clara-Altamirano, Miguel Ángel (Instituto Nacional de Cancerologia (Tlalpan)) ; Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ; Cuellar, M. (Instituto Nacional de Cancerologia (Tlalpan)) ; Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ; Domínguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ; Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Dufresne, Armelle (Léon Bérard Center (Lyon)) ; Eriksson, Mikael (Skane University Hospital (Lund)) ; Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ; Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ; Gouin, François (Léon Bérard Center (Lyon)) ; Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ; Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Jimenez, Natalia (Hospital San Vicente de Paúl (Heredia)) ; Karanian, Marie (Léon Bérard Center (Lyon)) ; Kasper, Bernd (University of Heidelberg (Mannheim)) ; Lopes, Artur (A.C.Camargo Cancer Center (Brasil)) ; Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ; Maki, Robert G. (University of Pennsylvania (New York)) ; Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ; Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ; Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ; Morales Pérez, José Manuel (Hospital Medica Sur (Mexico)) ; Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Nakagawa, Suely Akiko (A.C.Camargo Cancer Center (Brasil)) ; Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ; Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ; Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ; Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ; Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ; Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ; Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; MLG, Silva (A.C.Camargo Cancer Center (Brasil)) ; Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Valverde, Claudia María (Hospital Universitari Vall d'Hebron) ; Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ; Zamora Estrada, Esteban (Hospital Dr. R. A. Calderón Guardia (San José)) ; Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Bone sarcoma are infrequent diseases, representing < 0. 2% of all adult neoplasms. A multidisciplinary management within reference centers for sarcoma, with discussion of the diagnostic and therapeutic strategies within an expert multidisciplinary tumour board, is essential for these patients, given its heterogeneity and low frequency. [...]
2022 - 10.1016/j.critrevonc.2022.103685
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103685  

See also: similar author names
2 Collini, P.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.